title: A Case Report-Stevens-Johnson Syndrome as an Adverse Effect of Capecitabine.
authors.affiliation: Department of Gastrointestinal Medical Oncology, U.T. M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
authors.forename: Priyanka
authors.initials: P
authors.lastname: Jadhav
authors.affiliation: Pharmacy Clinical Programs, U.T. M.D. Anderson Cancer Center, Houston, TX, USA.
authors.forename: Jane E
authors.initials: JE
authors.lastname: Rogers
authors.affiliation: Department of Gastrointestinal Medical Oncology, U.T. M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. rshroff@mdanderson.org.
authors.forename: Rachna
authors.initials: R
authors.lastname: Shroff
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000069287:Capecitabine / Q000009:adverse effects*; D004379:Duodenal Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D013262:Stevens-Johnson Syndrome / Q000209:etiology* / Q000473:pathology
chemical_list: D000964:Antimetabolites, Antineoplastic; D000069287:Capecitabine